Twenty years after Europe licensed a testosterone treatment for women, the US Food and Drug Administration has asked for evidence on a use it has never approved. A new unreviewed study, meanwhile, raises questions about heart safety. In July 2006, the European...
Elinzanetant, a non-hormonal pill that acts on the brain’s temperature control centre, is under fast-track review in the US for hot flushes caused by breast cancer therapy. Regulators in the UK, the EU, Switzerland and Canada have already approved it for this...
